Lakefront Biotherapeutics (GLPGF) Change in Inventory (2015 - 2020)

Lakefront Biotherapeutics (GLPGF) has reported Change in Inventory for 6 consecutive years, with $120059.2 the latest figure, recorded in Q2 2020.

• On a quarterly basis, Change in Inventory rose 2236.97% year-over-year to $120059.2 in Q2 2020; TTM through Jun 2020 was $32832.9, a 358.13% increase from a year earlier, with the FY2025 full-year figure at $32.6 million, up 30.72% from the prior year.
• Change in Inventory was $120059.2 for Q2 2020 at Lakefront Biotherapeutics, up from -$68444.2 in the prior quarter.
• Over five years, Change in Inventory peaked at $21.1 million in Q3 2017 and troughed at -$19.8 million in Q2 2017.
• A 5-year average of $84842.6 and a median of -$3950.5 in 2018 frame the typical range for Change in Inventory.
• Across the five-year window, Change in Inventory slumped 67382.79% in 2017 and soared 2236.97% in 2020, its largest moves.
• Over 5 years, Change in Inventory stood at $29376.8 in 2016, then plunged by 196.19% to -$28258.4 in 2017, then soared by 91.92% to -$2282.8 in 2018, then sank by 1015.23% to -$25458.4 in 2019, then surged by 571.59% to $120059.2 in 2020.
• The last three Change in Inventory figures came in at $120059.2 (Q2 2020), -$68444.2 (Q1 2020), and -$25458.4 (Q4 2019), per Business Quant data.